Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12882847rdf:typepubmed:Citationlld:pubmed
pubmed-article:12882847lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:12882847lifeskim:mentionsumls-concept:C0150097lld:lifeskim
pubmed-article:12882847lifeskim:mentionsumls-concept:C0011881lld:lifeskim
pubmed-article:12882847lifeskim:mentionsumls-concept:C0003015lld:lifeskim
pubmed-article:12882847lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:12882847lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12882847lifeskim:mentionsumls-concept:C0521942lld:lifeskim
pubmed-article:12882847lifeskim:mentionsumls-concept:C0034866lld:lifeskim
pubmed-article:12882847lifeskim:mentionsumls-concept:C0205289lld:lifeskim
pubmed-article:12882847pubmed:issue8lld:pubmed
pubmed-article:12882847pubmed:dateCreated2003-7-28lld:pubmed
pubmed-article:12882847pubmed:abstractTextWe evaluated the renoprotective effects as reflected by short-term changes in albuminuria of dual blockade of the renin-angiotensin system (RAS) by adding an angiotensin II receptor blocker (ARB) to treatment with maximal recommended doses of an ACE inhibitor (ACEI) in patients with type 2 diabetes and nephropathy.lld:pubmed
pubmed-article:12882847pubmed:languageenglld:pubmed
pubmed-article:12882847pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882847pubmed:citationSubsetIMlld:pubmed
pubmed-article:12882847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882847pubmed:statusMEDLINElld:pubmed
pubmed-article:12882847pubmed:monthAuglld:pubmed
pubmed-article:12882847pubmed:issn0149-5992lld:pubmed
pubmed-article:12882847pubmed:authorpubmed-author:RossingKasper...lld:pubmed
pubmed-article:12882847pubmed:authorpubmed-author:ParvingHans-H...lld:pubmed
pubmed-article:12882847pubmed:authorpubmed-author:JacobsenPeter...lld:pubmed
pubmed-article:12882847pubmed:authorpubmed-author:PietraszekLot...lld:pubmed
pubmed-article:12882847pubmed:issnTypePrintlld:pubmed
pubmed-article:12882847pubmed:volume26lld:pubmed
pubmed-article:12882847pubmed:ownerNLMlld:pubmed
pubmed-article:12882847pubmed:authorsCompleteYlld:pubmed
pubmed-article:12882847pubmed:pagination2268-74lld:pubmed
pubmed-article:12882847pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:meshHeadingpubmed-meshheading:12882847...lld:pubmed
pubmed-article:12882847pubmed:year2003lld:pubmed
pubmed-article:12882847pubmed:articleTitleRenoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.lld:pubmed
pubmed-article:12882847pubmed:affiliationSteno Diabetes Center, Gentofte, Denmark. krossing@dadlnet.dklld:pubmed
pubmed-article:12882847pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12882847pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12882847pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:12882847pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882847lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882847lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882847lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882847lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882847lld:pubmed